Literature DB >> 15896479

Characterization of neural cell types expressing peroxiredoxins in mouse brain.

Mei-Hua Jin1, Young-Ho Lee, Jin-Man Kim, Hu-Nan Sun, Eun-Yi Moon, Min Ho Shong, Sun-Uk Kim, Sang Ho Lee, Tae-Hoon Lee, Dae-Yeul Yu, Dong-Seok Lee.   

Abstract

The differential expression patterns of antioxidant enzymes observed in the brains of patients with neurodegenerative diseases suggest an important role for reactive oxygen species and antioxidant enzymes in neurodegeneration. The six mammalian peroxiredoxins (Prxs) comprise a novel family of anti-oxidative proteins that are widely distributed in most tissues, but few studies of Prx in brain tissue have been reported. The specific histology of the neural cell types in which Prxs are expressed is an important issue related to biological function and defense against oxidative stress in the brain. This study analyzed mouse brain neural cell types expressing Prx isoforms using single- or double-label immunohistochemical techniques. In neurons, immunoreactivity for Prx II-V was observed in the cytoplasm. In particular, Prx II was found in the habenular nuclei, and Prx III and V were found in the stratum lucidum of the hippocampus. Astrocytes and microglia were immunoreactive only for Prx VI and Prx I, respectively. Prx I and IV immunoreactivity was apparent in oligodendrocytes, where it was principally localized in the nuclei. The observed distribution of Prx isoforms in the mammalian brain may be indicative of their specific roles in their preferred neural cell types and subcellular locales. The results of this study will help in unraveling the physiological and pathophysiological roles of the different Prx isoforms in neural function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896479     DOI: 10.1016/j.neulet.2005.02.048

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  47 in total

1.  Edaravone leads to proteome changes indicative of neuronal cell protection in response to oxidative stress.

Authors:  Mohammad-Saeid Jami; Zahra Salehi-Najafabadi; Fereshteh Ahmadinejad; Esthelle Hoedt; Morteza Hashemzadeh Chaleshtori; Mahdi Ghatrehsamani; Thomas A Neubert; Jan Petter Larsen; Simon Geir Møller
Journal:  Neurochem Int       Date:  2015-07-29       Impact factor: 3.921

2.  Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis.

Authors:  Nigar Fatma; E Kubo; M Sen; N Agarwal; W B Thoreson; C B Camras; D P Singh
Journal:  Brain Res       Date:  2008-07-29       Impact factor: 3.252

3.  Heterozygous knockout of the Bmi-1 gene causes an early onset of phenotypes associated with brain aging.

Authors:  Minxia Gu; Lihua Shen; Lei Bai; Junying Gao; Charles Marshall; Ting Wu; Jiong Ding; Dengshun Miao; Ming Xiao
Journal:  Age (Dordr)       Date:  2013-06-15

4.  Expression of Peroxiredoxin 1 After Traumatic Spinal Cord Injury in Rats.

Authors:  Shen Huang; Xiaojuan Liu; Jinlong Zhang; Guofeng Bao; Guanhua Xu; Yuyu Sun; Qijie Shen; Min Lian; Yuwei Huang; Zhiming Cui
Journal:  Cell Mol Neurobiol       Date:  2015-05-24       Impact factor: 5.046

5.  Upregulation of peroxiredeoxin III in the hippocampus of acute immobilization stress model rats and the Foxo3a-dependent expression in PC12 cells.

Authors:  Hee Jeong Jeong; Hee Won Jeong; Su Sung Song; Joon Won Kang; Je Hoon Seo; Young Ho Lee; Keon Su Lee; Dong Woon Kim
Journal:  Cell Mol Neurobiol       Date:  2011-05-12       Impact factor: 5.046

6.  Comparative study of Hsp27, GSK3β, Wnt1 and PRDX3 in Hirschsprung's disease.

Authors:  Hong Gao; Xiaomei Liu; Dong Chen; Liangying Lv; Mei Wu; Jie Mi; Weilin Wang
Journal:  Int J Exp Pathol       Date:  2014-04-29       Impact factor: 1.925

7.  Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade.

Authors:  Xiaoming Hu; Zhongfang Weng; Charleen T Chu; Lili Zhang; Guodong Cao; Yanqin Gao; Armando Signore; Jianhui Zhu; Teresa Hastings; J Timothy Greenamyre; Jun Chen
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

8.  Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors.

Authors:  Sally Järvelä; Immo Rantala; Alejandra Rodriguez; Heini Kallio; Seppo Parkkila; Vuokko L Kinnula; Ylermi Soini; Hannu Haapasalo
Journal:  BMC Cancer       Date:  2010-03-22       Impact factor: 4.430

9.  HIV-1-infected astrocytes and the microglial proteome.

Authors:  Tong Wang; Nan Gong; Jianuo Liu; Irena Kadiu; Stephanie D Kraft-Terry; Joshua D Schlautman; Pawel Ciborowski; David J Volsky; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2008-06-28       Impact factor: 4.147

10.  Mechanisms involved in the modulation of astroglial resistance to oxidative stress induced by activated microglia: antioxidative systems, peroxide elimination, radical generation, lipid peroxidation.

Authors:  Claudia Röhl; Elisabeth Armbrust; Eva Herbst; Anne Jess; Michael Gülden; Edmund Maser; Gerald Rimbach; Christine Bösch-Saadatmandi
Journal:  Neurotox Res       Date:  2009-09-10       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.